• Forward Look

    Your Tax Dollars at Work

    Q&A with Joseph Unger on publicly funded cancer research.

    by Sue Rochman

  • Forward Look

    Scientists Take a Stand

    Thousands of attendees who gathered at the Opening Ceremony of the American Association for Cancer Research (AACR) Annual Meeting 2017 sent a message on April 2 that cuts proposed by the Trump administration to the National Institutes of Health (NIH) budget would be devastating to cancer research, stall progress and ultimately harm cancer patients. The Annual […]

    by Sue Rochman

  • A New Look for Clinical Trials

    More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.

    by Sue Rochman

  • Forward Look

    More Options for Adolescents in Clinical Trials

    New recommendations support inclusion of teens in adult studies.

    by Susan Kreimer

  • Survivor Profile

    The Gift of Music

    A self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.

    by Jenny Song

  • Q&A

    Trial Guide

    Researcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.

    by Kate Yandell

  • Get Involved

    A Home Away From Home

    Ann W. Calahan started Joe's House to help cancer patients and others find places to stay when they're being treated away from home.

    by Cameron Walker

  • AACR Scientist↔Survivor Program: The Patient Perspective

    In a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.

    by Marci A. Landsmann

  • Patient Advocates Go to Washington

    Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.

    by Marci A. Landsmann

  • The Affordable Care Act and Cancer Patients

    Cancer survivors tell their stories and researchers take a broad view.

    by Kevin McLaughlin